Corneal lymphangiogenesis: Evidence, mechanisms, and implications for corneal transplant immunology

Cornea

Volumn 22, Issue 3, 2003, Pages 273-281

  Cursiefen, Claus ^a   Chen, Lu ^a   Dana, M Reza ^a   Streilein, J Wayne ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

Antilymphangiogenic therapy; Cornea; Corneal transplantation; Immune privilege; Lymphangiogenesis

Indexed keywords

GENE PRODUCT; MOLECULAR MARKER; PODOPLANIN; PROTEIN LYVE 1; PROTEIN PROX 1; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 3;

ALLOIMMUNIZATION; ANGIOGENESIS; ARTICLE; CORNEA TRANSPLANTATION; EFFECTOR CELL; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOCOMPETENT CELL; LYMPH NODE; LYMPH VESSEL; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; CORNEAL DISEASES; CORNEAL TRANSPLANTATION; ENDOTHELIUM, LYMPHATIC; GRAFT SURVIVAL; HUMANS; LYMPHATIC SYSTEM; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0037378711     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-200304000-00021     Document Type: Article

References (85)

1. Streilein JW, Yamada J, Dana MR, et al. Anterior chamber-associated immune deviation, ocular immune privilege, and orthotopic corneal allografts. Transplant Proc 1999;31:1472-5.
2. Dana MR, Streilein JW. Loss and restoration of immune privilege in eyes with corneal neovascularization. Invest Ophthalmol Vis Sci 1996;37:2485-94.
3. Dana MR, Schaumberg DA, Kowal VO, et al. Corneal neovascularization after penetrating keratoplasty. Cornea 1995;14:604-9.
4. Cursiefen C, Wenkel H, Martus P, et al. Impact of short- versus longterm topical steroids on corneal neovascularization after non-high-risk keratoplasty. Graefe Arch Clin Exp Ophthalmol 2001;239:514-21.
5. Cursiefen C, Küchle M, Naumann GOH. Angiogenesis in corneal diseases: Histopathology of 254 human corneal buttons with neovascularization. Cornea 1998;17:611-3.
6. Skobe M, Hawighorst T, Jackson DG, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001;7:192-8.
7. Paavonen K, Puolakkainen P, Jussila L, et al. Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am J Pathol 2000;156:1499-504.
8. Skobe M, Hamberg LM, Hawighorst T, et al. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am J Pathol 2001;159:893-903.
9. Collin HB, Kenyon KR, Rowsey JJ. Lymphatic vessels in chemically burned human corneas. Cornea 1986;5:223-8.
10. Collin HB. Corneal lymphatics in alloxan vascularized rabbit eyes. Invest Ophthalmol 1966;5:1-13.
11. Collin HB. A quantitative electron microscopic study of growing corneal lymphatic vessels. Exp Eye Res 1974;18:171-80.
12. Collin HB. The fine structure of growing corneal lymphatic vessels. J Pathol 1971;104:99-113.
13. Collin HB. Ultrastructure of lymphatic vessels in the vascularized rabbit cornea. Exp Eye Res 1970;10:207-13.
14. Collin HB. Lymphatic drainage of 131-I-albumin from the vascularized cornea. Invest Ophthalmol 1970;9:146-55.
15. Collin HB. Endothelial cell lined lymphatics in the vascularized rabbit cornea. Invest Ophthalmol 1966;5:337-54.
16. Boneham GC, Collin HB. Steroid inhibition of limbal blood and lymphatic vascular cell growth. Curr Eye Res 1995;14:1-10.
17. Junghans BM, Collin HB. Limbal lymphangiogenesis after corneal injury: an autoradiographic study. Curr Eye Res 1989;8:91-100.
18. Szalay J, Pappas GD. Fine structure of rat corneal vessels in advanced stages of wound healing. Invest Ophthalmol 1970;9:354-65.
19. Smolin G, Hyndiuk RA. Lymphatic drainage from vascularized rabbit cornea. Am J Ophthalmol 1971;72:147-51.
20. Cursiefen C, Schlötzer-Schrehardt U, Küchle M, et al. Lymphatic vessels in vascularized human corneas: Immunohistochemical investigation using LYVE-1 and Podoplanin. Invest Ophthalmol Vis Sci 2002;43:2127-35.
21. Kaipainen A, Korhonen J, Mustonen T, et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci U S A 1995;92:3566-70.
22. Lymboussaki A, Achen MG, Stacker SA, et al. Growth factors regulating lymphatic vessels. Curr Top Microbiol Immunol 2000;251:75-82.
23. Oh SJ, Jeltsch M, Birkenhäger R, et al. VEGF and VEGF-C: Specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol 1997;188:96-109.
24. Cao Y, Linden P, Farnebo J, et al. Vascular endothelial growth factor C induces angiogenesis in vivo. Proc Natl Acad Sci U S A 1998;95:14389-94.
25. Partanen TA, Alitalo K, Miettinen M. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Cancer 1999;86:2406-12.
26. Partanen TA, Arola J, Saaristo A, et al. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J 2000:14:2087-96.
27. Mimura T, mano S, Usui T, et al. Expression of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in corneal lymphangiogenesis. Exp Eye Res 2001;72:71-8.
28. Breiteneder-Geleff S, Matsui K, Soleiman A, et al. Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is downregulated in puromycin nephrosis. Am J Pathol 1997;151:1141-52.
29. Breiteneder-Geleff S, Soleiman A, Kowalski H, et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: Podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 1999;154:385-94.
30. Sinzelle E. Van Huyen JP, Breiteneder-Geleff S, et al. Intrapericardial lymphangioma with Podoplanin immunohistochemical characterization of lymphatic endothelial cells. Histopathology 2000;37:85-95.
31. Weninger W, Partanen TA, Breiteneder-Geleff S, et al. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. Lab Invest 1999;79:243-51.
32. Banerji S, Ni J, Wang SX, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999;144:789-801.
33. Prevo R, Banerji S, Ferguson DJP, et al. Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J Biol Chem 2001;276:19420-30.
34. Carreira CM, Nasser SM, di Tomaso E, et al. LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and downregulation in human liver cancer and cirrhosis. Cancer Res 2001;61:8079-84.
35. Wigle JT, Harvey N, Detmar M, et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 2002;21:1505-13.
36. Wigle JT, Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell 1999;98:769-78.
37. Karkkainen MJ, Alitalo K. Lymphatic endothelial regulation, lymphedema, and lymph node metastasis. Semin Cell Dev Biol 2002;13:9-18.
38. Jackson DG. New molecular markers for the study of tumor lymphangiogenesis. Anticancer Res 2001;21:4279-83.
39. Karkkainen M, Mäkinen T, Alitalo K. Lymphatic endothelium: a new frontier of metastasis research. Nat Cell Biol 2002;4:2-5.
40. Karkkainen MJ, Saaristo A, Jussila L, et al. A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci U S A 2001;98:12677-82.
41. Oliver G, Detmar M. The rediscovery of the lymphatic system: old and new insights into the development and biologic function of the lymphatic vasculature. Gene Dev 2002;16:773-83.
42. Swartz MA, Skobe M. Lymphatic function, lymphangiogenesis, and cancer metastasis. Microsc Res Tech 2001;15:92-9.
43. Skobe M, Detmar M. Structure, function, and molecular control of the skin lymphatic system. J Invest Dermatol Symp Proc 2000;5:14-9.
44. Schneider M, Othman-Hassan K, Christ B, et al. Lymphangioblasts in the avian wing bud. Dev Dyn 1999;216:311-9.
45. Salven P, Mustjoki S, Alitalo R, et al. VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells. Blood (in press).
46. Chang JH, Gabison EE, Kato T, et al. Corneal neovascularization. Curr Opin Ophthalmol 2001;12:242-9.
47. Campochiaro PA. Retinal and choroidal neovascularization. J Cell Physiol 2000;184:301-10.
48. Beasley NJP, Prevo R, Banerji S, et al. Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 2002;62:1315-20.
49. Schoppmann SF. Birner P, Studer P, et al. Lymphatic microvessel density and lymphovascular invasion assessed by anti-Podoplanin immunostaining in human breast cancer. Anticancer Res 2001;21:2351-5.
50. He Y, Kozaki K, Karpanen T, et al. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst 2002;94:819-25.
51. Padera TP, Kadambi A, di Thomaso E, et al. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 2002;296:1883-6.
52. Casley-Smith JR. The fine structure and functioning of tissue channels and lymphatics. Lymphology 1980;12:177-83.
53. Leak LV. Electron microscopic observations on lymphatic capillaries and the structural components of the connective tissue-lymph interface. Microvasc Res 1970;2:361-91.
54. Sleeman JP, Krishnan J, Kirkin V, et al. Markers of the lymphatic endothelium: in search of the holy grail? Microsc Res Tech 2001;55:61-9.
55. Galle MB, DeFranco RM, Kerjaschki D, et al. Ordered array of dendritic cells and CD8+ lymphocytes in portal infiltrates in chronic hepatitis C. Histopathology 2001;39:373-81.
56. Cursiefen C, Rummelt C, Breiteneder-Geleff S, et al. Orbital lymphangioma with positive immunohistochemistry of lymphatic endothelial markers (VEGF R3, Podoplanin). Graefe Arch Clin Exp Ophthalmol 2001;239:628-32.
57. Jackson DG, Prevo R. Clasper S, et al. LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trends Immunol 2001;22:317-21.
58. Kriehuber E, Breiteneder-Geleff S, Groeger M, et al. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J Exp Med 2001;194:797-808.
59. Enholm B, Karpanen T, Jeltsch M, et al. Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin. Circ Res 2001;88:623-9.
60. Hong YK, Harvey N, Noh YH, et al. Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev Dyn 2002;225:351-7.
61. Nibbs RJ, Kriehuber E, Ponath PD, et al. The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am J Pathol 2001;158:867-77.
62. Ristimäki A, Narko K, Enholm B, et al. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem 1998;273:8413-8.
63. Stacker SA, Caesar C, Baldwin ME, et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 2001;7:186-91.
64. Makinen T, Jussila L, Veikkola T, et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med 2001;7:199-205.
65. Karkkainen MJ, Ferrell RE, Lawrence EC, et al. Missense mutations interfere with VEGFR-3 signaling in primary lymphedema. Nat Genet 2000;25:153-9.
66. Dumont D, Jussila L, Taipale J, et al. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 1998;282:946-9.
67. Nagy JA, Vasile E, Feng D, et al. Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med 2002;196:1497-506.
68. Huang XZ, Wu JF, Ferrando R, et al. Fatal bilateral chylothorax in mice lacking the integrin α9β1. Mol Cell Biol 2000;20:5208-15.
69. Clark ER, Clark EL. Observations on the new growth of lymphatic vessels as seen in transparent chambers introduced into rabbit's ear. Am J Anat 1932;51:49-87.
70. Witmer AN, van Blijswijk, Dai J, et al. VEGFR-3 in adult angiogenesis. J Pathol 2001;195:490-7.
71. Cursiefen C, Rummelt C, Küchle M, et al. Pericyte recruitment in human corneal angiogenesis. Br J Ophthalmol 2003;87:101-6.
72. Clarijs R, Schalkwijk L, Ruiter DJ, et al. Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma. Invest Ophthalmol Vis Sci 2001;42:1422-8.
73. Phillip WE, Speicher L. Expression of vascular endothelial growth factors, VEGF B, VEGF C, VEGF D, and of VEGF C receptors, FLT-4 (VEGFR-3) in inflamed and vascularized human corneas. Invest Ophthalmol Vis Sci 2002;43:S1755.
74. Kubo H, Cao R, Bräkenhielm E, et al. Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea. Proc Natl Acad Sci U S A 2002;99:8868-73.
75. Zhu S, Dekaris I, Duncker G, et al. Early expression of proinflammatory cytokines interleukin-1 and tumor necrosis factor-alpha after corneal transplantation. J Interferon Cytokine Res 1999;19:661-9.
76. Yamagami S, Dana MR. The critical role of lymph nodes in corneal alloimmunization and graft rejection. Invest Ophthalmol Vis Sci 2001;42:1293-8.
77. Yamagami S, Dana MR, Tsuru T. Draining lymph nodes play an essential role in alloimmunity generated in response to high-risk corneal transplantation. Cornea 2002;21:405-9.
78. Hamrah P, Zhang Q, Dana MR. Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in the conjunctiva: a potential link between lymphangiogenesis and leukocyte trafficking on the ocular surface. Adv Exp Med Biol 2002;851-8.
79. Dana MR, Qian Y, Hamrah P. Twenty-five-year panorama of corneal immunology. Cornea 2000;19:625-43.
80. Termeer C, Benedix F, Sleeman J, et al. Oligosaccharides of hyaluronan activate dendritic cells via Toll-like receptor 4. J Exp Med 2002:195:99-111.
81. Liu Y, Hamrah P, Zhang Q, et al. Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive dendritic cells derived from MHC class II-negative grafts. J Exp Med 2002;195:1-11.
82. Fernandez Pujol B, Lucibello FC, Zuzarte M, et al. Dendritic cells derived from peripheral monocytes express endothelial markers and in the presence of angiogenic growth factors differentiate into endothelial-like cells. Eur J Cell Biol 2001;80:99-110.
83. Fitzsimmons TD, Molander N, Stenevi U, et al. Endogenous hyaluronan in corneal disease. Invest Ophthalmol Vis Sci 1994;35:2774-82.
84. Gan L, Fagerholm P. Leukocytes in the early events of corneal neovascularization. Cornea 2001;20:96-9.
85. Weber BA, Fagerholm P, Johansson B. Colocalization of hyaluronan and water in rabbit corneas after photorefractive keratectomy by specific staining for hyaluronan and by quantitative microradiography. Cornea 1997;16:560-3.